A Biomarker Screening Protocol for Participants With Solid Tumors

NCT05891197 · clinicaltrials.gov ↗
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped Pipeline Reprioritization

Conditions

Sponsor

Lyell Immunopharma, Inc.

Collaborators